Resumen

Systemic antifungal drugs used to treat serious fungal disease fall chiefly into three drug classes-azoles, echinocandins, and polyenes. A fourth class, pyrimidine analogues, consists of a single agent, flucytosine, that is only used in combination with other antifungals. Both azoles and polyenes target the cell membrane, while echinocandins specifically target cell wall synthesis. This chapter details drugs mechanisms of action, spectrum of activity, pharmacokinetics, and toxicities associated with the clinical use of currently approved systemic antifungals to treat life-threatening mycoses. In addition to drug characteristics, the detection and interpretation of antifungal resistance is discussed for common clinically relevant species.

Idioma originalEnglish (US)
Título de la publicación alojadaDiagnosis and Treatment of Fungal Infections
Subtítulo de la publicación alojadaThird Edition
EditorialSpringer International Publishing
Páginas125-147
Número de páginas23
ISBN (versión digital)9783031358036
ISBN (versión impresa)9783031358029
DOI
EstadoPublished - sept 14 2023

ASJC Scopus subject areas

  • General Medicine

Huella

Profundice en los temas de investigación de 'Systemic antifungal agents'. En conjunto forman una huella única.

Citar esto